REFERENCES
- Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthlamol. 1981; 65: 417–422.
- Yeo JH, Marcus S, Murphy RP. Retinal pigment epithelial tears. Ophthalmology. 1988; 95:8–13.
- Decker WL, Sanborn GE, Ridley M, et al. Retinal pigment epithelial tears. Ophthalmology. 1983; 90:507–512
- Gass JDM. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol. 1984; 68:513–519.
- Emerson GG, Ghazi NG. Spontaneous rip of the retinal pigment epithelium with a macular hole in neovascular age-related macular degeneration. Am J Ophthalmol. 2005; 140(2):316–318.
- Bressler NM, Finklestein D, Sunness JS, et al. Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol. 1990; 108:1694–1697.
- Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye. 1988; 2:106–113.
- Arroyo JG, Schatz H, McDonald R, Johnson RN. Indocyanine green videoangiography after acute retinal pigment epithelial tears in age-related macular degeneration. Am J Ophthalmol. 1997; 123:377–385.
- Giovannini A, Amato G, Mariotti C, et al. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina. 2000; 20:37–40.
- Karadimas P, Paleokastritis GP, Bouzas EA. Fundus autofluorescence imaging findings in retinal pigment epithelial tear. Euro J Ophthalmol. 2006; 16(5):767–769.
- Gass JDM. Serous retinal pigment epithelial detachment with a notch. Retina. 1984; 4:205–220.
- Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009; 147:644–652.
- Lafaut BA, Aisenbrey S, Vanden Broecke C, et al. Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol. 2001; 85:454–460.
- Krishan NR, Chandra SR, Stevens TS. Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol. 1985; 100:698–707.
- Hartnett ME, Lappas A, Darland D, et al. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res. 2003; 77:593–99.
- Ghassemifar R, Lai CM, Rakoczy PE. VEGF differentially regulates transcription and translation of ZO-1a+ and ZO-1a- in cultured endothelial and epithelial cells. Cell Tissue Res. 2006; 323:117–125.
- Ablonczy Z, Crosson CE. VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007; 85:762–71.
- Peng S, Adelman RA, Rizzolo LJ. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci. 2010; 51(6):3216–25.
- Miura Y, Klettner A, Roider J. VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: Possible participation of intracellular glutathione. Invest Ophthalmol Vis Sci. 2010; 51(9):4848–55.
- Meyer CH, Toth CA. Retinal pigment epithelial tear with vitreomacular detachment: A novel pathogenic feature. Graefe’s Arch Clin Exp Ophthalmol. 2001; 239:235–333.
- Levin LA, Seddon JM, Topping T. Retinal pigment epithelial tears associated with trauma. Am J Ophthalmol. 1991; 112(4):396–400.
- Chuang EL, Bird AC. The pathogenesis of tears of the retinal pigment epithelium. Am J Ophthalmol. 1988; 105:285–290.
- Toth CA, Pasquale AC, Graichen DF. Clinicopathologic correlation of spontaneous retinal pigment epithelial tears with choroidal neovascular membranes in age-related macular degeneration. Ophthalmology. 1995; 102:272–277.
- Starita C, Hussain AA, Patmore A, Marshall J. Localization of the site of major resistance to fluid transport in Bruch’s membrane. Invest Ophthalmol Vis Sci. 1997; 38:762–767.
- Chuang EL, Bird AC. Bilaterality of tears of the retinal pigment epithelium. Br J Ophthalmol. 1988; 72:918–920.
- Schoeppner G, Chuang EL, Bird AC. The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol. 1989; 108:683–685.
- Kroyer K, la Cour M, Larsen M. Dissociation of rod and cone sensitivity by acute localized retinal pigment epithelium loss. Acta Ophthalmol. 2008; 86:338–340.
- Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of vitamin A in cone-dominant retinas: A novel pathway for visual-pigment regeneration in daylight. Neuron. 2002; 36(1):69–80.
- Iijima H, Gohdo T. Visual field change in eyes with retinal pigment epithelial tear. Retina. 1999; 19:198–203.
- Maguire JI, Annesley WH, Decker WL, et al. Computerised visual field deficits in tears of the retinal pigment epithelium. Br J Ophthalmol. 1990; 74:556–558.
- Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: Classification and outcome. Br J Ophthalmol. 1985; 69:397–403.
- Pauleikhoff D, Loffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefe’s Arch Clin Exp Ophthalmol. 2002; 240:533–538.
- Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments: A study of 40 eyes. Arch Ophthalmol. 1990; 108:1687–1693.
- Barondes MJ, Pagliarini S, Chisholm IH, et al. Controlled trial of laser photocoagulation of pigment epithelial detatchments in the elderly: 4 year review. Br J Ophthalmol. 1992; 76:5–7.
- Gass JDM. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol. 1984; 98:700–706.
- Thompson JT. Retinal pigment epithelial tear after transpupillary thermotherapy for choroidal neovascularization. Am J Ophthalmol. 2001; 131(5):662–664.
- Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina. 2001; 21(6):661–665.
- Gelisken F, Inhoffen W, Partsch M, et al. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol. 2001; 131:518–520.
- Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye. 2005; 19:1315–1324.
- Michels S, Aue A, Simader C, et al. Retinal pigment epithelium tears following verteporphin therapy combined with intravitreal triamcinolone. Am J Ophthalmol. 2006; 141:396–398.
- Lommatzsch A, Heimes B, Gutfleisch M, et al. Serous pigment epithelial detachment in age related macular degeneration: Comparison of different treatments. Eye. 2009; 23:2163–2168.
- Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina. 2008; 28:1265–1269.
- Dhalla MS, Blinder KJ, Tewari A, et al. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol. 2006; 141:752–754.
- Chang LK, Flaxel CJ, Lauer AK, Sarraf D. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina. 2007; 27:857–863.
- Singh RP, Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol. 2006; 142:160–162.
- Shah CP, Hsu J, Garg SJ, et al. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol. 2006; 142:1070–1071.
- Arias L, Caminal JM, Rubio M, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol. 2007; 17(6):992–995.
- Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularized PED secondary to AMD. Graefe’s Arch Clin Exp Ophthalmol. 2007; 245:1037–1040.
- Weinberger AWA, Thiel M, Mohammadi B, et al. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. Am J Ophthalmol. 2007; 144:294–296.
- Kook D, Wolf A, Neubauer AS, et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe. 2008; 105:158–164.
- Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularization secondary to age related macular degeneration. Br J Ophthalmol. 2006; 90:1207–1208.
- Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2007; 27:535–540.
- Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina. 2007; 27:541–551.
- Chang LK, Sarraf D. Tears of the retinal pigment epithelium. An old problem in a new era. Retina. 2007; 27:523–534.
- Garg S, Brod R, Kim D, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Clin and Exp Ophthalmol. 2008; 36:252–256.
- Forooghian F, Cukras C, Chew EY. Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment. Can J Ophthalmol. 2008; 43(2):246–248.
- Leitreitz M, Gelisken F, Inhoffen W, et al. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye. 2008; 22:1504–1507.
- Gelisken F, Ziemssen F, Voelker M, et al. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye. 2009; 23:694–702.
- Moroz I, Moisseiev J, Alhalel A. Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection. Ophthalmic Surg Lasers Imaging. 2009; 40:570–575.
- Chan CK, Abraham P, Meyer CH, et al. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina. 2010; 30(2):203–11.
- Wong LJ, Desai RU, Jain A, et al. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Retina. 2008; 28:1151–1158.
- Spandau UHM, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2006; 142:1068–1070.
- Smith BT, Kraus CL, Apte RS. Retinal pigment epithelial tears in ranibizumab-treated eyes. Retina. 2009; 29:335–339.
- Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2007; 143:504–505.
- Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol. 2007; 143:505–507.
- Kiss C, Michels S, Prager F, et al. Retinal pigment epithelium tears following intravitreal ranibizumab therapy. Acta Ophthalmol. Scand. 2007; 85:902–903.
- Konstantinidis L, Ambresin A, Zografos L, Mantel I. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration. Acta Ophthalmol Scand. 2010; 88(7):736–41.
- Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355:1419–1431.
- Sarraf D, Reddy S, Chiang A, et al. A new grading system for retinal pigment epithelial tears. Retina. 2010; 30:1039–1045.
- Polito A, Cereda M, Romanelli F, Pertile G. Macular translocation with 360º retinotomy for management of retinal pigment epithelial tear: Long-term results. Br J Ophthalmol. 2011; 95(1):74–8.